| __timestamp | ADMA Biologics, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9517014 | 241751000 |
| Thursday, January 1, 2015 | 7015946 | 322292000 |
| Friday, January 1, 2016 | 7688238 | 344320000 |
| Sunday, January 1, 2017 | 6229587 | 374644000 |
| Monday, January 1, 2018 | 3926120 | 414604000 |
| Tuesday, January 1, 2019 | 2343848 | 466000000 |
| Wednesday, January 1, 2020 | 5907013 | 535000000 |
| Friday, January 1, 2021 | 3646060 | 643000000 |
| Saturday, January 1, 2022 | 3613764 | 833000000 |
| Sunday, January 1, 2023 | 3300000 | 899625000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals, Inc. and ADMA Biologics, Inc. have demonstrated contrasting approaches to R&D investment.
Ionis Pharmaceuticals has consistently increased its R&D expenses, with a remarkable 272% growth from 2014 to 2023. This surge underscores Ionis's dedication to pioneering new therapies and maintaining its leadership in the biotech sector. By 2023, Ionis's R&D spending reached nearly $900 million, reflecting its strategic focus on innovation.
In contrast, ADMA Biologics has shown a more conservative R&D investment strategy, with a 65% decrease in spending over the same period. This trend may indicate a shift in focus or resource allocation, potentially impacting its competitive edge in the market.
Comparing Innovation Spending: Merck & Co., Inc. and ADMA Biologics, Inc.
United Therapeutics Corporation or Ionis Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Viatris Inc. and ADMA Biologics, Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and Ionis Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Verona Pharma plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and Amicus Therapeutics, Inc.
R&D Spending Showdown: Ionis Pharmaceuticals, Inc. vs MorphoSys AG
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Iovance Biotherapeutics, Inc.
Research and Development: Comparing Key Metrics for ADMA Biologics, Inc. and Viridian Therapeutics, Inc.